Multifaceted role of RNA editing in promoting loss-of-function of PODXL in cancer

Ting Fu; Tracey W Chan; Jae Hoon Bahn; Tae-Hyung Kim; Amy C Rowat; Xinshu Xiao

doi:10.1016/j.isci.2022.104836

Multifaceted role of RNA editing in promoting loss-of-function of PODXL in cancer

iScience. 2022 Aug 2;25(8):104836. doi: 10.1016/j.isci.2022.104836. eCollection 2022 Aug 19.

Authors

Ting Fu¹, Tracey W Chan², Jae Hoon Bahn³, Tae-Hyung Kim³, Amy C Rowat^{1

3}, Xinshu Xiao^{1

2

3}

Affiliations

¹ Molecular, Cellular, and Integrative Physiology Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90095, USA.
² Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90095, USA.
³ Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Abstract

PODXL, a protein that is dysregulated in multiple cancers, plays an important role in promoting cancer metastasis. In this study, we report that RNA editing promotes the inclusion of a PODXL alternative exon. The resulting edited PODXL long isoform is more prone to protease digestion and has the strongest effects on reducing cell migration and cisplatin chemoresistance among the three PODXL isoforms (short, unedited long, and edited long isoforms). Importantly, the editing level of the PODXL recoding site and the inclusion level of the PODXL alternative exon are strongly associated with overall patient survival in Kidney Renal Clear Cell Carcinoma (KIRC). Supported by significant enrichment of exonic RNA editing sites in alternatively spliced exons, we hypothesize that exonic RNA editing sites may enhance proteomic diversity through alternative splicing, in addition to amino acid changes, a previously under-appreciated aspect of RNA editing function.

Keywords: Biological sciences; bioinformatics; cancer; omics.

Abstract

Grants and funding